Development Level

Tbio 2 | 10,625
Tchem 2 | 1,890
Tclin 1 | 602

Disease

Asthma 5 | 349
Cancer 5 | 2,346
Alzheimer's disease 4 | 644
Complex regional pain syndrome 4 | 12
Huntington's disease 4 | 72
Neuropathy 4 | 210
Pain agnosia 4 | 99
Parkinson's disease 4 | 364
Schizophrenia 4 | 501
diabetes mellitus 4 | 1,663
Allergic hypersensitivity disease 3 | 123
Bipolar Disorder 3 | 266
Cerebrovascular disease 3 | 231
Cocaine-Related Disorders 3 | 88
Cystitis 3 | 16
Dementia 3 | 129
Dermatitis 3 | 107
Epicondylitis 3 | 19
Hyperalgesia 3 | 71
Inflammation 3 | 109
Inflammatory bowel disease 3 | 142
Irritable bowel syndrome 3 | 59
Major Depressive Disorder 3 | 106
Migraine 3 | 79
Neurogenic Inflammation 3 | 12
Pain disorder 3 | 13
Rhinitis 3 | 46
glioblastoma 3 | 5,572
psoriasis 3 | 6,685
Alcohol dependence 2 | 107
Amnesia 2 | 17
Amyotrophic Lateral Sclerosis 2 | 431
Anxiety disorder 2 | 22
Arthritis 2 | 248
Attention deficit hyperactivity disorder 2 | 156
Autistic Disorder 2 | 320
Autonomic neuropathy 2 | 21
Bradycardia 2 | 24
Bronchial Hyperreactivity 2 | 13
Constipation 2 | 43
Down syndrome 2 | 548
Epilepsy 2 | 346
Fibromyalgia 2 | 22
Glaucoma 2 | 134
Heroin dependence 2 | 30
Hyperactive behavior 2 | 31
Hypertension 2 | 287
Motion sickness 2 | 32
Multiple Sclerosis 2 | 498
Narcolepsy 2 | 58
Nerve Degeneration 2 | 73
Obesity 2 | 616
Pancreatitis 2 | 97
Parkinson Disease 2 | 102
Seizures 2 | 95
Spinocerebellar ataxia type 23 2 | 2
Status Epilepticus 2 | 85
Substance Withdrawal Syndrome 2 | 52
Tonic-clonic epilepsy 2 | 47
Toxic encephalopathy 2 | 131
Urticaria 2 | 53
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
group 4 medulloblastoma 2 | 1,875
interstitial cystitis 2 | 2,299
invasive ductal carcinoma 2 | 2,950
medulloblastoma, large-cell 2 | 6,234
nervous system disorder 2 | 53
oligodendroglioma 2 | 2,849
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 1,530
Alcoholic Intoxication, Chronic 1 | 41
Amnestic disorder 1 | 37
Anorexia nervosa 1 | 59
Anxiety Disorders 1 | 37
Arthritis, Experimental 1 | 39
Brain disease 1 | 83
Bronchitis 1 | 44
Bulimia nervosa 1 | 15
Child Development Disorders, Pervasive 1 | 55
Depressive disorder 1 | 48
Diarrhea 1 | 155
Drug Eruptions 1 | 18
Eating disorder 1 | 24
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Gliosis 1 | 16
Glomerulonephritis 1 | 36
Hepatitis C 1 | 90
Hirschsprung's disease 1 | 42
Infarction, Middle Cerebral Artery 1 | 25
Osteoarthritis 1 | 96
Pain 1 | 70
Panic disorder 1 | 55
Sensorineural hearing loss 1 | 107
Sudden infant death syndrome 1 | 33
chronic kidney disease 1 | 90
interstitial lung disease 1 | 291
obsessive-compulsive disorder 1 | 34

Tissue

Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Nervous System 5 | 18,561
Blood and immune system 4 | 17,995
Cardiovascular System 4 | 17,958
Digestive Tract 4 | 18,473
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Respiratory system 4 | 17,484
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444

Target Family

Non-IDG 4 | 11,971
GPCR 1 | 406

Grant Application

2R01HL035812-14A2 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Beta-nerve growth factor NGF Tchem Non-IDG -3.99294 10626.8 510
Substance-P receptor TACR1 Tclin GPCR -3.08170 1193.3 417
Brain-derived neurotrophic factor BDNF Tbio Non-IDG -3.94336 9826.7 594
Neuropeptide S NPS Tchem Non-IDG -3.89942 7090.5 86
Protachykinin-1 TAC1 Tbio Non-IDG -4.12709 13651.7 395